相关实验视频
Updated: May 15, 2026

13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
17.5K
生物信息学查和验证与缺血性中风相关的关键基因和药物预测
Shuai Jiang1, Zhanhui Liu1, Xian Zhang1
1Department of Neurosurgery, The Ninth Hospital of Xi'an, Xi'an, China.
General physiology and biophysics
|August 14, 2024
概括
这项研究确定了涉及中风的关键基因和途径,揭示了潜在的治疗点. 罗利普拉姆证明了保护作用,在缺血性中风后显著减少神经行为功能障碍.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 脑卒中是全球残疾和死亡的主要原因,需要新的治疗策略.
- 目前对中风的医疗治疗方法有限,这凸显了迫切需要新的治疗点.
研究的目的:
- 在中风模型中识别差异表达基因 (DEGs).
- 探索中风的生物过程和潜在的治疗点.
- 在中风模型中评估罗利普拉姆的神经保护作用.
主要方法:
- 两种基因表达综合 (GEO) 微阵列数据集的元分析.
- 不同基因表达分析和功能丰富分析 (DAVID, Metascape).
- 枢纽基因鉴定 (Cytoscape),基因表达验证 (实时PCR,西部斑),以及药物查 (Cmap).
- 在实体中评估罗利普拉姆的疗效,使用过渡性中脑动脉阻塞 (tMCAO) 后的行为测试.
主要成果:
- 在中脑动脉封闭 (MCAO) 和对照组之间确定了27个共享的DEG.
- 丰富分析显示了DEG参与免疫反应,补充和凝固级联,以及亡.
- 确定了四个枢纽基因 (C1qc,Fcgr2b,C1qb,Cd14),其中C1q和CD14的表达在tMCAO后增加.
- 在tMCAO的14天后,罗利普拉姆治疗显著减轻了神经行为缺陷.
结论:
- 这项研究提供了关于中风的分子机制的见解,特别是免疫和凝固途径.
- 确定C1q和CD14作为潜在的生物标志物或中风治疗点.
- 罗利普拉姆作为减轻中风诱导的神经行为功能障碍的治疗剂具有前景.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

